Y Intercept Hong Kong Ltd Boosts Holdings in Reinsurance Group of America, Incorporated $RGA

Y Intercept Hong Kong Ltd grew its holdings in shares of Reinsurance Group of America, Incorporated (NYSE:RGA) by 126.3% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 41,880 shares of the insurance provider’s stock after acquiring an additional 23,376 shares during the quarter. Y Intercept Hong Kong Ltd’s holdings in Reinsurance Group of America were worth $8,521,000 at the end of the most recent quarter.

Several other large investors have also recently made changes to their positions in RGA. Activest Wealth Management purchased a new position in shares of Reinsurance Group of America during the fourth quarter worth approximately $30,000. International Assets Investment Management LLC purchased a new position in shares of Reinsurance Group of America during the fourth quarter worth approximately $35,000. Advisory Services Network LLC purchased a new position in shares of Reinsurance Group of America during the third quarter worth approximately $38,000. Entrust Financial LLC purchased a new position in shares of Reinsurance Group of America during the fourth quarter worth approximately $40,000. Finally, Thurston Springer Miller Herd & Titak Inc. raised its stake in shares of Reinsurance Group of America by 632.1% during the fourth quarter. Thurston Springer Miller Herd & Titak Inc. now owns 205 shares of the insurance provider’s stock worth $42,000 after acquiring an additional 177 shares in the last quarter. 95.11% of the stock is owned by hedge funds and other institutional investors.

Reinsurance Group of America Stock Up 2.2%

Shares of NYSE RGA opened at $210.63 on Friday. The company has a quick ratio of 0.14, a current ratio of 0.14 and a debt-to-equity ratio of 0.46. Reinsurance Group of America, Incorporated has a 52 week low of $165.52 and a 52 week high of $229.21. The firm’s fifty day moving average is $208.20 and its 200 day moving average is $205.62. The company has a market cap of $13.80 billion, a price-to-earnings ratio of 11.41 and a beta of 0.47.

Reinsurance Group of America (NYSE:RGA) last issued its earnings results on Thursday, May 7th. The insurance provider reported $6.97 EPS for the quarter, topping the consensus estimate of $6.03 by $0.94. The company had revenue of $6.49 billion for the quarter, compared to the consensus estimate of $6.47 billion. Reinsurance Group of America had a net margin of 4.92% and a return on equity of 13.16%. The firm’s revenue for the quarter was up 23.5% on a year-over-year basis. During the same period in the previous year, the firm earned $5.66 earnings per share. On average, equities research analysts expect that Reinsurance Group of America, Incorporated will post 26.88 earnings per share for the current year.

Reinsurance Group of America Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 2nd. Shareholders of record on Tuesday, May 19th were given a dividend of $0.93 per share. This represents a $3.72 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date of this dividend was Tuesday, May 19th. Reinsurance Group of America’s payout ratio is presently 20.15%.

Analyst Upgrades and Downgrades

Several research analysts recently commented on RGA shares. Wall Street Zen raised shares of Reinsurance Group of America from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. Morgan Stanley lifted their target price on shares of Reinsurance Group of America from $208.00 to $223.00 and gave the stock an “equal weight” rating in a research note on Tuesday, March 3rd. Evercore reaffirmed an “outperform” rating and issued a $267.00 target price on shares of Reinsurance Group of America in a research note on Monday, May 18th. UBS Group lifted their target price on shares of Reinsurance Group of America from $216.00 to $220.00 and gave the stock a “neutral” rating in a research note on Thursday, April 9th. Finally, Wells Fargo & Company lifted their target price on shares of Reinsurance Group of America from $238.00 to $261.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 25th. Seven analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Reinsurance Group of America has a consensus rating of “Moderate Buy” and an average price target of $251.25.

Insiders Place Their Bets

In other Reinsurance Group of America news, EVP John W. Hayden sold 414 shares of the business’s stock in a transaction on Wednesday, May 20th. The shares were sold at an average price of $214.95, for a total transaction of $88,989.30. Following the transaction, the executive vice president directly owned 20,949 shares of the company’s stock, valued at approximately $4,502,987.55. The trade was a 1.94% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Ronald Herrmann sold 7,000 shares of the business’s stock in a transaction on Thursday, May 14th. The shares were sold at an average price of $210.58, for a total transaction of $1,474,060.00. Following the transaction, the executive vice president directly owned 3,938 shares in the company, valued at approximately $829,264.04. The trade was a 64.00% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.60% of the stock is currently owned by insiders.

Reinsurance Group of America Profile

Reinsurance Group of America, Incorporated (NYSE: RGA) is a leading global provider of life and health reinsurance solutions. Headquartered in St. Louis, Missouri, RGA partners with primary insurance companies to help them manage risk, improve capital efficiency and develop innovative products. The company’s offerings span traditional risk transfer, financial solutions and facultative underwriting services, enabling clients to address a wide range of mortality, longevity, morbidity and critical-illness exposures.

RGA’s product suite includes life reinsurance, living benefits reinsurance, structured reinsurance and financial solutions that support product innovation and capital management.